Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Salsoso, Rocio ^a   Guzman Gutierrez, Enrique ^a   Arroyo, Pablo ^a   Salomon, Carlos ^a,c   Zambrano, Sonia ^b   Victoria Ruiz Armenta, Maria ^b   Blanca, Antonio Jesus ^b   Pardo, Fabian ^a   Leiva, Andrea ^a   Mate, Alfonso ^b   Sobrevia, Luis ^a,c   Vazquez, Carmen Maria ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CARNITINE; CARNITINE TRANSPORTER 1; CARNITINE TRANSPORTER 2; MESSENGER RNA; SODIUM ION;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CELL PH; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; EXTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; AORTA; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CARNITINE; CARRIER PROTEINS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTENSION; KINETICS; MALE; MEMBRANE PROTEINS; ORGANIC CATION TRANSPORT PROTEINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SODIUM; TISSUE CULTURE TECHNIQUES; VASODILATION;

EID: 84896511491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090339     Document Type: Article

References (44)

1. Melander O (2001) Genetic factors in hypertension-what is known and what does it mean? Blood Press 10: 254-270. (Pubitemid 34083352)
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) ESH/ESC 2007 Guidelines for the management of arterial hypertension. Rev Esp Cardiol 60: 968-994.
3. Arduini A, Bonomini M, Savica V, Amato A, Zammit V (2008) Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther 120: 149-156.
4. Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, et al. (2009) Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension 54: 567-574.
5. Rajasekar P, Palanisamy N, Anuradha CV (2007) Increase in nitric oxide and reductions in blood pressure, protein kinase C beta II and oxidative stress by Lcarnitine: a study in the fructose-fed hypertensive rat. Clin Exp Hypertens 29: 517-530. (Pubitemid 350223251)
6. Furuichi Y, Sugiura T, Kato Y, Shimada Y, Masuda K (2010) OCTN2 is associated with carnitine transport capacity of rat skeletal muscles. Acta Physiol 200: 57-64.
7. McCarty MF (2004) A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets. Med Hypotheses 62: 62-71. (Pubitemid 38200007)
8. Miguel-Carrasco JL, Mate A, Monserrat MT, Arias JL, Aramburu O, et al. (2008) The role of inflammatory markers in the cardioprotective effect of Lcarnitine in L-NAME-induced hypertension. Am J Hypertens 21: 1231-1237.
9. Gómez-Amores L, Mate A, Miguel-Carrasco JL, Jiménez L, Jos A, et al. (2007) L-Carnitine attenuates oxidative stress in hypertensive rats. J Nutr Biochem 18: 533-540. (Pubitemid 47043414)
10. Sharma S, Aramburo A, Rafikov R, Sun X, Kumar S, et al. (2013) L-Carnitine preserves endothelial function in a lamb model of increased pulmonary blood flow. Pediatr Res 74: 39-47.
11. Volek JS, Judelson DA, Silvestre R, Yamamoto LM, Spiering BA, et al. (2008) Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults. Am J Cardiol 102: 1413-1417.
12. Tamai I (2013) Pharmacological and pathophysiological roles of carnitine/ organic cation transporters (OCTNs: SLC22A4, SLC22A5 and SLC22A21). Biopharm Drug Dispos 34: 29-44.
13. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, et al. (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pHdependent transport of organic cations. J Pharmacol Exp Ther 289: 768-773. (Pubitemid 29191230)
14. Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, et al. (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 102: 5256-5261.
15. Mo JX, Shi SJ, Zhang Q, Gong T, Sun X, et al. (2011) Synthesis, transport and mechanism of a type I prodrug: L-carnitine ester of prednisolone. Mol Pharm 8: 1629-1640.
16. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, et al. (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275: 40064-40072. (Pubitemid 32064631)
17. Enomoto A, Wempe MF, Tsuchida H, Shin HJ, Cha SH, et al. (2002) Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem 277: 36262-36271.
18. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, et al. (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273: 20378-20382. (Pubitemid 28377603)
19. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V (1999) Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem 274: 33388-33392. (Pubitemid 129511642)
20. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, et al. (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290: 1482-1492. (Pubitemid 29400294)
21. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, et al. (1999) Na + -dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291: 778-784. (Pubitemid 29503553)
22. Ohashi R, Tamai I, Nezu J, Nikaido H, Hashimoto N, et al. (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59: 358-366. (Pubitemid 32108570)
23. Okura T, Kato S, Deguchi Y (2013) Functional expression of organic cation/ carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model. Drug Metab Pharmacokinet. doi: 10.2133/dmpk.DMPK-13-RG-058.
24. Herrera MD, Bueno R, De Sotomayor MA, Pérez-Guerrero C, Vázquez CM, et al. (2002) Endothelium-dependent vasorelaxation induced by L-carnitine in isolated aorta from normotensive and hypertensive rats. J Pharm Pharmacol 54: 1423-1427. (Pubitemid 35174191)
25. Bueno R, Alvarez de Sotomayor M, Perez-Guerrero C, Gomez-Amores L, Vazquez CM, et al. (2005) L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products. Life Sci 77: 2082-2097. (Pubitemid 41140450)
26. Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Arévalo M, et al. (2013) L-Carnitine protects against arterial hypertension-related cardiac fibrosis through modulation of PPAR-c expression. Biochem Pharmacol 85: 937-944.
27. Oza NB, Schwartz JH, Goud HD, Levinsky NG (1990) Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest 85: 597-600. (Pubitemid 20070072)
28. Guzmán-Gutiérrez E, Westermeier F, Salomón C, González M, Pardo F, et al. (2012) Insulin-increased L-arginine transport requires A2A adenosine receptors activation in human umbilical vein endothelium. PLoS One 7: e41705.
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT Method. Methods 25: 402-408. (Pubitemid 34164012)
30. Kanakasabai S, Pestereva E, Chearwae W, Gupta SK, Ansari S, et al. (2012) PPARc agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. PLoS One 7: e50500.
31. Mels CM, Schutte AE, Erasmus E, Huisman HW, Schutte R, et al. (2013) Lcarnitine and long-chain acylcarnitines are positively correlated with ambulatory blood pressure in humans: the SABPA study. Lipids 48: 63-73.
32. Tamai I, Yabuuchi H, Nezu J, et al. (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419: 107-111. (Pubitemid 28011227)
33. Srinivas SR, Prasad PD, Umapathy NS, Ganapathy V, Shekhawat PS (2007) Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Am J Physiol 293: G1046-G1053. (Pubitemid 350106559)
34. Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24: 1227-1251. (Pubitemid 46876495)
35. Koepsell H (2013) The SLC22 family with transporters of organic cations, anions and zwitterions. Mol Aspects Med 34: 413-435.
36. Devés R, Boyd CA (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487-545. (Pubitemid 28182902)
37. Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83: 183-252. (Pubitemid 36459881)
38. Iwata D, Kato Y, Wakayama T, Sai Y, Kubo Y, et al. (2008) Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. Drug Metab Pharmacokinet 23: 207-215.
39. Urban TJ, Yang C, Lagpacan LL, Brown C, Castro RA, et al. (2007) Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4). Pharmacogenet Genomics 17: 773-782. (Pubitemid 47263072)
40. Grube M, Meyer zu Schwabedissen HE, Präger D, Haney J, Möritz KU, et al. (2006) Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113: 1114-1122.
41. Foster KA, O'Rourke B, Reibel DK (1985) Altered carnitine metabolism in spontaneously hypertensive rats. Am J Physiol 249: 183-186.
42. Shennan DB, Calvert DT, Backwell FR, Boyd CA (1998) Peptide aminonitrogen transport by the lactating rat mammary gland. Biochim Biophys Acta 1373: 252-260. (Pubitemid 28495685)
43. Wu X, Prasad PD, Leibach FH, Ganapathy V (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246: 589-595. (Pubitemid 28420901)
44. Aravena C, Beltrán AR, Cornejo M, Torres V, Díaz ES, et al. (2012) Potential role of sodium-proton exchangers in the low concentration arsenic trioxideincreased intracellular pH and cell proliferation. PLoS One 7: e51451.